Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-04-05
2005-04-05
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S112000, C546S183000
Reexamination Certificate
active
06875774
ABSTRACT:
The present invention discloses novel cholinergic receptor ligands. The present invention also relates to the synthesis of substituted derivatives of aza-bridged bicyclic amines for use as muscarinic receptor ligands as well as methods of regulating function of certain cholinergic receptors, and hence acting as antagonists, agonists and partial agonists at certain specific cholinergic receptor subtypes. The present invention also relates to methods for treating disorders associated with cholinergic receptors.
REFERENCES:
patent: 4870081 (1989-09-01), Orlek et al.
patent: 5397800 (1995-03-01), Alker et al.
patent: 5468875 (1995-11-01), Sabb et al.
patent: 5510486 (1996-04-01), Robinson, III et al.
patent: 5578602 (1996-11-01), Sauerberg et al.
patent: 5658925 (1997-08-01), Miyazawa et al.
patent: 6211204 (2001-04-01), Messer et al.
patent: 6211377 (2001-04-01), de Schrijver et al.
patent: 6369081 (2002-04-01), Rajeswaran et al.
patent: 4116582 (1991-11-01), None
patent: 0 094 742 (1983-11-01), None
patent: 0 214 772 (1987-03-01), None
patent: 0 239 321 (1987-09-01), None
patent: 0 257 741 (1988-03-01), None
patent: 0 287 356 (1988-10-01), None
patent: WO 9207854 (1992-05-01), None
patent: WO 9308191 (1993-04-01), None
patent: WO 9515073 (1993-08-01), None
King et al, J. Med. Chem. vol. 36, p. 683-689 (1993).*
McElvain et al, JACS, vol.35, p. 2750 (1923).*
Zaitseva et al, Farmakologiya i Toksikologiya (Moscow) vol. 27,No. 6,p. 686-690 (1964).*
King et al., “Substituted Benzamides with Conformationally Restricted Side Chains. 5. Azabicyclo[x,y,z] Derivatives as 5-HT4Receptor Agonists and Gastric Motility Stimulants”Journal of Medicinal Chemistry36 (6): 683-689 (1993).
Orlek et al., “Comparison of Azabicyclic Esters and Oxidiazoles as Ligands for the Muscarinic Receptor,”Journal of Medicinal Chemistry34 (9): 2726-2735 (1991).
Sternbach et al., “Antispasmodics. I: Bicyclic Basic Alcohols”,Journal of the American Chemical Society74 2215-2218 (1952).
International Search Report, PCT/US01/21406, Oct. 23, 2002.
Christopoulos et al.,Synthesis and Pharmacological Evaluation of Dimeric Muscarinic Acetylcholine Receptor Agonists, The Journal of Pharmacology and Experimental Therapeutics, vol. 298, No. 3, 2001, pp. 1260-1968.
Felder et al.,Therapeutic Opportunities for Muscarinic Receptors in the Central Nervous System, Journal of Medicinal Chemistry, vol. 43, No. 23, Nov. 16, 2000, pp. 4333-4353.
Gohlke et al.,Synthesis and Nicotinic Binding Studies on Enantiopure Diazine Analogues of the Novel(2-Chloro-5-pyridyl)-9-azabicyclo[4.2.1]non-2-ene UB-165, Journal of Medicinal Chemistry, vol. 45, No. 5, 2002, pp. 1064-1072.
Martell, Jr. et al.,Esters of Bicyclic Aminoalcohols as Potential Anticholinergics III, Journal of Pharmaceutical Sciences, vol. 52, No. 4, Apr. 1963, pp. 331-336.
McPherson et al.,Structure Elucidation Via Stereoselective Synthesis of the Acetate Center of 1-Azabicyclo[2.2.2]oct-3-yl α-Hydroxy-α-(1-iodo-1-propen-3-yl)-α-phenylacetate(INQP).A High Affinity Muscarinic Imaging Agent for SPECT, Journal of Organic Chemistry, vol. 61, 1996, pp. 8335-8337.
Portoghese,Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists, Trends Pharmacol. Sci, vol. 10, 1989, pp. 230,235.
Portoghese,From Models to Molecules: Opioid Receptors Dimers, Bivalent Ligands, and Selective Opioid Receptor Probes, Journal of Medicinal Chemistry, vol. 44, No. 14, Jul. 5, 2001, pp. 2259-2269.
Rajeswaran et al.,Design, Synthesis, and Biological Characterization of Bivalent 1-Methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole Derivatives as Selective Muscarinic Agonists, Journal of Medicinal Chemistry, vol. 44, No. 26, pp. 4563-4576.
Sternbach et al.,Antispasmodics. II. Esters of Basic Bicyclic Alcohols, Journal of the American Chemical Society, vol. 74, May 5, 1952, pp. 2219-2221.
Sternbach et al.,Antispasmodics. I. Bicyclic Basic Alcohols, Journal of the American Chemical Society, vol. 74, May 5, 1952, pp. 2215-2218.
Tecle et al.,CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology, Pharmaceutica Acta Helvetiae , vol. 74, 2000, pp. 141-148.
Bodor Erik
Harden T. Kendall
Kim Myoung Goo
Kohn Harold
Dentz Bernard
Myers Bigel Sibley and Sajovec, P.A.
The University of North Carolina
LandOfFree
Aza-bridged bicyclic amine derivatives for use as novel... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aza-bridged bicyclic amine derivatives for use as novel..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aza-bridged bicyclic amine derivatives for use as novel... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3386142